share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT

SEC announcement ·  May 1 15:42
Summary by Moomoo AI
Pfizer Inc. (PFE) Chairman & CEO Albert Bourla executed a transaction of non-derivative securities on April 30, 2024. The specific details of the transaction, including the number of shares, transaction price, and total value, were not disclosed in the announcement. Following the action, the updated number of shares held by Bourla was not provided. This transaction is part of the regular financial disclosures made by company executives, which are closely monitored by investors for insights into executive confidence and company performance.
Pfizer Inc. (PFE) Chairman & CEO Albert Bourla executed a transaction of non-derivative securities on April 30, 2024. The specific details of the transaction, including the number of shares, transaction price, and total value, were not disclosed in the announcement. Following the action, the updated number of shares held by Bourla was not provided. This transaction is part of the regular financial disclosures made by company executives, which are closely monitored by investors for insights into executive confidence and company performance.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more